Search research articles
Contact Us
Filters
Showing results (51-60 of 105) with videos related to
Page
of 11
Sort By:
The Journal of Pathology
|
October 15, 2013
Metastatic progression of breast cancer: insights from 50 years of autopsies
Margaret C Cummings, Peter T Simpson, Lynne E Reid, et al.
Cancer Research
|
July 25, 2014
Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer
Thomas W Owens, Renee L Rogers, Sarah Best, et al.
Nature Communications
|
January 16, 2026
Robust and interpretable prediction of gene markers and cell types from spatial transcriptomics data
Xiao Tan, Onkar Mulay, Jacky Xie, et al.
Oncotarget
|
May 10, 2014
Rad51 supports triple negative breast cancer metastasis
Adrian P Wiegmans, Fares Al-Ejeh, Nicole Chee, et al.
Breast Cancer Research and Treatment
|
June 22, 2012
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression
Ana Cristina Vargas, Amy E McCart Reed, Nic Waddell, et al.
The American Journal of Surgical Pathology
|
May 18, 2005
Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis
Peter T Simpson, Theo Gale, Jorge S Reis-Filho, et al.
Therapeutic Advances in Medical Oncology
|
October 5, 2020
Clinicopathologic significance of nuclear HER4 and phospho-YAP(S<sup>127</sup>) in human breast cancers and matching brain metastases
Priyakshi Kalita-de Croft, Malcolm Lim, Haarika Chittoory, et al.
Oncotarget
|
April 26, 2014
Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
Fares Al-Ejeh, Mariska Miranda, Wei Shi, et al.
NPJ Precision Oncology
|
September 13, 2023
Deep spatial-omics analysis of Head & Neck carcinomas provides alternative therapeutic targets and rationale for treatment failure
Andrew Causer, Xiao Tan, Xuehan Lu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 9, 2013
Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor
Fares Al-Ejeh, Wei Shi, Mariska Miranda, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 105) with videos related to
Sort By:
Page
of 11
The Journal of Pathology
|
October 15, 2013
Metastatic progression of breast cancer: insights from 50 years of autopsies
Margaret C Cummings, Peter T Simpson, Lynne E Reid, et al.
Cancer Research
|
July 25, 2014
Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer
Thomas W Owens, Renee L Rogers, Sarah Best, et al.
Nature Communications
|
January 16, 2026
Robust and interpretable prediction of gene markers and cell types from spatial transcriptomics data
Xiao Tan, Onkar Mulay, Jacky Xie, et al.
Oncotarget
|
May 10, 2014
Rad51 supports triple negative breast cancer metastasis
Adrian P Wiegmans, Fares Al-Ejeh, Nicole Chee, et al.
Breast Cancer Research and Treatment
|
June 22, 2012
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression
Ana Cristina Vargas, Amy E McCart Reed, Nic Waddell, et al.
The American Journal of Surgical Pathology
|
May 18, 2005
Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis
Peter T Simpson, Theo Gale, Jorge S Reis-Filho, et al.
Therapeutic Advances in Medical Oncology
|
October 5, 2020
Clinicopathologic significance of nuclear HER4 and phospho-YAP(S<sup>127</sup>) in human breast cancers and matching brain metastases
Priyakshi Kalita-de Croft, Malcolm Lim, Haarika Chittoory, et al.
Oncotarget
|
April 26, 2014
Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
Fares Al-Ejeh, Mariska Miranda, Wei Shi, et al.
NPJ Precision Oncology
|
September 13, 2023
Deep spatial-omics analysis of Head & Neck carcinomas provides alternative therapeutic targets and rationale for treatment failure
Andrew Causer, Xiao Tan, Xuehan Lu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 9, 2013
Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor
Fares Al-Ejeh, Wei Shi, Mariska Miranda, et al.
Page
of 11